These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9816106)

  • 1. Biological and molecular analysis of a low-grade recurrence of a glioblastoma multiforme.
    Scheck AC; Shapiro JR; Coons SW; Norman SA; Johnson PC
    Clin Cancer Res; 1996 Jan; 2(1):187-99. PubMed ID: 9816106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA content and chromosomal composition of malignant human gliomas.
    Bigner SH; Bjerkvig R; Laerum OD
    Neurol Clin; 1985 Nov; 3(4):769-84. PubMed ID: 3001489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic and flow cytometry DNA analysis of regional heterogeneity in a low grade human glioma.
    Coons SW; Johnson PC; Shapiro JR
    Cancer Res; 1995 Apr; 55(7):1569-77. PubMed ID: 7882367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of DCC expression and glioma progression.
    Reyes-Mugica M; Rieger-Christ K; Ohgaki H; Ekstrand BC; Helie M; Kleinman G; Yahanda A; Fearon ER; Kleihues P; Reale MA
    Cancer Res; 1997 Feb; 57(3):382-6. PubMed ID: 9012460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast.
    Kleer CG; Giordano TJ; Braun T; Oberman HA
    Mod Pathol; 2001 Mar; 14(3):185-90. PubMed ID: 11266524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of the main genetic markers in glioblastoma multiforme is independent of tumor topology.
    Necesalová E; Vranová V; Kuglík P; Cejpek P; Jarosová M; Pesáková M; Relichová J; Veselská R
    Neoplasma; 2007; 54(3):212-8. PubMed ID: 17447852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of glioblastoma multiforme provides evidence for subgroups within the grade.
    Mohapatra G; Bollen AW; Kim DH; Lamborn K; Moore DH; Prados MD; Feuerstein BG
    Genes Chromosomes Cancer; 1998 Mar; 21(3):195-206. PubMed ID: 9523194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines.
    Roversi G; Pfundt R; Moroni RF; Magnani I; van Reijmersdal S; Pollo B; Straatman H; Larizza L; Schoenmakers EF
    Oncogene; 2006 Mar; 25(10):1571-83. PubMed ID: 16247447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of two cell lines derived from human glioblastoma multiforme.
    Bacciocchi G; Gibelli N; Zibera C; Pedrazzoli P; Bergamaschi G; De Piceis Polver P; Danova M; Mazzini G; Palomba L; Tupler R
    Anticancer Res; 1992; 12(3):853-61. PubMed ID: 1320358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
    Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
    Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ki-67 as a marker of proliferation activity in tumor progression of recurrent gliomas of supratentorial localization. Immunocytochemical quantitative studies.
    Kałuza J; Adamek D; Pyrich M
    Pol J Pathol; 1997; 48(1):31-6. PubMed ID: 9200958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.
    Kuan CT; Wakiya K; Dowell JM; Herndon JE; Reardon DA; Graner MW; Riggins GJ; Wikstrand CJ; Bigner DD
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1970-82. PubMed ID: 16609006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between laminin-8 and glial tumor grade, recurrence, and patient survival.
    Ljubimova JY; Fugita M; Khazenzon NM; Das A; Pikul BB; Newman D; Sekiguchi K; Sorokin LM; Sasaki T; Black KL
    Cancer; 2004 Aug; 101(3):604-12. PubMed ID: 15274074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivation of human neurotropic JC virus expressing oncogenic protein in a recurrent glioblastoma multiforme.
    Del Valle L; Azizi SA; Krynska B; Enam S; Croul SE; Khalili K
    Ann Neurol; 2000 Dec; 48(6):932-6. PubMed ID: 11117551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically heterogeneous glioblastoma recurring with disappearance of 1p/19q losses: case report.
    Ito M; Wakabayashi T; Natsume A; Hatano H; Fujii M; Yoshida J
    Neurosurgery; 2007 Jul; 61(1):E168-9; discussion E169. PubMed ID: 17621007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastomatous recurrence of oligodendroglioma remote from the original site: a case report.
    Kocaeli H; Yakut T; Bekar A; Taşkapilioğlu O; Tolunay S
    Surg Neurol; 2006 Dec; 66(6):627-30; discussion 630-1. PubMed ID: 17145331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs.
    Nabors LB; Gillespie GY; Harkins L; King PH
    Cancer Res; 2001 Mar; 61(5):2154-61. PubMed ID: 11280780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.